Dáil Éireann Debate, Tuesday - 23 June 2020
75. Deputy Róisín Shortall asked the Minister for Finance the terms of the funding by the Ireland Strategic Investment Fund to a company (details supplied); if the decision to invest over €70 million was taken after consultation with experts in genomic research and data protection not affiliated with the company; if further investment in the company is being considered; and if he will make a statement on the matter. [12396/20]
Amharc ar fhreagraInvestments made by the Ireland Strategic Investment Fund (ISIF) are made on a commercial basis, in line with ISIF’s statutory mandate to support economic activity in Ireland and deliver a commercial return. As the Deputy may know, under the statutory governance structure of the National Treasury Management Agency (NTMA) as it relates to the ISIF, investment decisions are approved by the NTMA’s Investment Committee. The Deputy will appreciate that it would not be appropriate, as Minister for Finance, for me to comment on the details of the commercial relationship between ISIF, the NTMA and any of its investee companies. However, I am informed that, as with all investments from the ISIF, the NTMA undertook customary due diligence as part of this transaction. I am also informed that the company itself made information on the transaction publicly available at the time.
